In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: Emerging resistance
- 1 January 1999
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 106 (1), 80-85
- https://doi.org/10.1016/s0161-6420(99)90008-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of Ciprofloxacin Ophthalmic Solution 0.3% to Fortified Tobramycin-Cefazolin in Treating Bacterial Corneal UlcersOphthalmology, 1996
- Fluoroquinolones in the Treatment of Bacterial KeratitisAmerican Journal of Ophthalmology, 1996
- Differential Care of Corneal Ulcers in the Community Based on Apparent SeverityOphthalmology, 1996
- Efficacy of Ofloxacin vs Cefazolin and Tobramycin in the Therapy for Bacterial KeratitisArchives of Ophthalmology (1950), 1995
- 0.3% Ciprofloxacin Ophthalmic Ointment in the Treatment of Bacterial KeratitisArchives of Ophthalmology (1950), 1993
- Ciprofloxacin-resistant Bacterial KeratitisAmerican Journal of Ophthalmology, 1993
- Comparison of Topical Ciprofloxacin to Conventional Antibiotic Therapy in the Treatment of Ulcerative KeratitisAmerican Journal of Ophthalmology, 1993
- Ciprofloxacin-resistant Bacterial KeratitisAmerican Journal of Ophthalmology, 1992
- An In Vitro Study of the Potency and Stability of Fortified Ophthalmic Antibiotic PreparationsAmerican Journal of Ophthalmology, 1991
- Mechanism of Ciprofloxacin Resistance in Pseudomonas aeruginosaThe Journal of Infectious Diseases, 1988